Arecoline-induced growth arrest and p21WAF1 expression are dependent on p53 in rat hepatocytes
- 14 January 2008
- journal article
- Published by Elsevier BV in Toxicology
- Vol. 243 (1-2), 1-10
- https://doi.org/10.1016/j.tox.2007.09.003
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Arecoline inhibits the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1A1 activation in human hepatoma cellsJournal of Hazardous Materials, 2007
- Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline in albino miceToxicology, 2006
- Role of Nitric Oxide in High Glucose-Induced Mitogenic Response in Renal FibroblastsMolecular Endocrinology, 2006
- Dysregulation of growth factor signaling in human hepatocellular carcinomaOncogene, 2006
- The in vivo comet assay: use and status in genotoxicity testingMutagenesis, 2005
- Liver fibrosisJCI Insight, 2005
- The Induction of Prostaglandin E2 Production, Interleukin-6 Production, Cell Cycle Arrest, and Cytotoxicity in Primary Oral Keratinocytes and KB Cancer Cells by Areca Nut Ingredients Is Differentially Regulated by MEK/ERK ActivationOnline Journal of Public Health Informatics, 2004
- Metabolic effects of the consumption of Areca catechuAddiction Biology, 2002
- Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease*Clinical Pharmacology & Therapeutics, 1996
- Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 PromoterOnline Journal of Public Health Informatics, 1995